Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 01, 2015 16:30 ET | Source: MacroGenics, Inc.

MacroGenics Announces Presentation at 30th Annual SITC Meeting 2015

ROCKVILLE, Maryland, Oct. 01, 2015 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative...
September 22, 2015 16:30 ET | Source: MacroGenics, Inc.

MacroGenics to Participate in Two Upcoming Investor Conferences

ROCKVILLE, Md., Sept. 22, 2015 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal...
September 03, 2015 16:30 ET | Source: MacroGenics, Inc.

MacroGenics to Participate in Two Upcoming Investor Conferences

ROCKVILLE, Md., Sept. 03, 2015 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal...
August 05, 2015 16:05 ET | Source: MacroGenics, Inc.

MacroGenics Provides Update on Corporate Progress and Second Quarter 2015 Financial Results

-- Fourth bi-specific DART® molecule, MGD011, in clinical testing -- Margetuximab Phase 3 SOPHIA metastatic breast cancer study initiated ...
August 04, 2015 16:05 ET | Source: MacroGenics, Inc.

MacroGenics to Present at the 2015 Wedbush PacGrow Healthcare Conference

Rockville, MD, Aug. 04, 2015 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal...
July 29, 2015 16:05 ET | Source: MacroGenics, Inc.

MacroGenics Announces Date of Second Quarter 2015 Financial Results Conference Call

ROCKVILLE, Md, July 29, 2015 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX) today announced that on Wednesday, August 5, 2015, the Company will release its financial results for the...
July 28, 2015 07:00 ET | Source: MacroGenics, Inc.

MGD011 Advances Into Clinical Development

— Triggers $10 million milestone payment from Janssen — Fourth DART® molecule to enter the clinic in last 12 months ROCKVILLE, Md., July 28, 2015 (GLOBE NEWSWIRE) -- MacroGenics,...
July 14, 2015 21:53 ET | Source: MacroGenics, Inc.

MacroGenics Announces Pricing of Public Offering of Common Stock

ROCKVILLE, Md., July 14, 2015 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq:MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based...
July 13, 2015 16:01 ET | Source: MacroGenics, Inc.

MacroGenics Announces Proposed Public Offering of Common Stock

ROCKVILLE, Md., July 13, 2015 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq:MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based...
May 30, 2015 09:05 ET | Source: MacroGenics, Inc.

MacroGenics Presents Updated Data from Phase 1 Study of Margetuximab at ASCO Annual Meeting 2015

ROCKVILLE, Md., May 30, 2015 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq:MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based...